HK1076476A1 - Ptprk immunogenic peptide - Google Patents

Ptprk immunogenic peptide

Info

Publication number
HK1076476A1
HK1076476A1 HK05108927A HK05108927A HK1076476A1 HK 1076476 A1 HK1076476 A1 HK 1076476A1 HK 05108927 A HK05108927 A HK 05108927A HK 05108927 A HK05108927 A HK 05108927A HK 1076476 A1 HK1076476 A1 HK 1076476A1
Authority
HK
Hong Kong
Prior art keywords
ptprk
immunogenic peptide
diagnosis
cells
cancer immunotherapy
Prior art date
Application number
HK05108927A
Other languages
English (en)
Inventor
Castelli Chiara
Parmiani Giorgio
Original Assignee
Ist Naz Stud Cura Dei Tumori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Naz Stud Cura Dei Tumori filed Critical Ist Naz Stud Cura Dei Tumori
Publication of HK1076476A1 publication Critical patent/HK1076476A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A61K2039/876—Skin, melanoma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK05108927A 2002-11-14 2005-10-10 Ptprk immunogenic peptide HK1076476A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT002412A ITMI20022412A1 (it) 2002-11-14 2002-11-14 Peptidi immunogeni di ptprk.
PCT/EP2003/012638 WO2004043988A2 (en) 2002-11-14 2003-11-12 Ptprk immunogenic peptide

Publications (1)

Publication Number Publication Date
HK1076476A1 true HK1076476A1 (en) 2006-01-20

Family

ID=32310164

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05108927A HK1076476A1 (en) 2002-11-14 2005-10-10 Ptprk immunogenic peptide

Country Status (12)

Country Link
US (1) US20060159691A1 (xx)
EP (1) EP1560848B1 (xx)
JP (1) JP2006506064A (xx)
AT (1) ATE383371T1 (xx)
AU (1) AU2003293677A1 (xx)
DE (1) DE60318608T2 (xx)
DK (1) DK1560848T3 (xx)
ES (1) ES2299748T3 (xx)
HK (1) HK1076476A1 (xx)
IT (1) ITMI20022412A1 (xx)
PT (1) PT1560848E (xx)
WO (1) WO2004043988A2 (xx)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863755A (en) * 1993-04-21 1999-01-26 Max Planck Gessellschaft Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ

Also Published As

Publication number Publication date
WO2004043988A8 (en) 2005-08-25
JP2006506064A (ja) 2006-02-23
DE60318608D1 (de) 2008-02-21
EP1560848A2 (en) 2005-08-10
ES2299748T3 (es) 2008-06-01
WO2004043988A3 (en) 2004-10-14
ATE383371T1 (de) 2008-01-15
DE60318608T2 (de) 2009-01-15
WO2004043988A2 (en) 2004-05-27
EP1560848B1 (en) 2008-01-09
US20060159691A1 (en) 2006-07-20
DK1560848T3 (da) 2008-05-26
ITMI20022412A1 (it) 2004-05-15
AU2003293677A1 (en) 2004-06-03
PT1560848E (pt) 2008-04-08

Similar Documents

Publication Publication Date Title
WO2002064057A3 (en) Use of cell penetrating peptides to generate antitumor immunity
HK1093014A1 (en) Microsome vaccine
AU2001298049A1 (en) Hla class i and ii binding peptides and their uses
MXPA05008128A (es) Peptidos derivados de survivina y uso de los mismos.
WO2001094944A3 (en) Artificial antigen presenting cells and methods of use thereof
CY1113044T1 (el) Παραλλαγματα αντιγονου αρχεγονων κυτταρων προστατη (psca) και υποαλληλουχιες εξ αυτων
ATE512666T1 (de) Hla-bindende peptide und ihre verwendungen
AU2003213580A1 (en) Subtilisin carlsberg proteins with reduced immunogenicity
HK1141540A1 (en) Hsp peptides and analogs for modulation of immune responses via antigen presenting cells hsp
AU2002309259A1 (en) Improved polysaccharide and glycoconjugate vaccines_____________
TR200102034T2 (tr) Anti kanser aşılaması için antikorların kullanılması
AU2003241127A1 (en) MEMBRANE-ANCHORED Beta2 MICROGLOBULIN COVALENTLY LINKED TO MHC CLASS I PEPTIDE EPITOPES
AU7615900A (en) Isolated peptides which bind to mhc class ii molecules, and uses thereof
DE69720065D1 (de) Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen
HK1076476A1 (en) Ptprk immunogenic peptide
AU2003245781A1 (en) Mhc class ii peptide epitope of 5t4 antigen
AU5690400A (en) Novel compounds
EP2193804A3 (en) Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens
WO2003091383A3 (fr) Epitopes t de l'antigene epha2.
PT996636E (pt) Antigenio ha-1
AU2003217758A1 (en) Cytokines and cytokine receptors with reduced immunogenicity
AU2000273396A1 (en) Hla binding peptides and their uses
PL371675A1 (en) Method for mapping and eliminating t-cell epitopes
WO2023044016A3 (en) Antibody immune-stimulant conjugates and use thereof
EP1605039A4 (en) DENDRITIC CELL HAVING ALPHA-GLYCOSYLCERAMIDE DERIVATIVES AND ANTIGEN AND USEFUL IN REMOVAL OF IMMUNE RESPONSE

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111112